TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/11/23 20:25 | 10/11/23 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Smith Brandon S. | CA | O | COO | S.d | -187 | 46.75 | 0 | -4 | -100 | 0 | D | ||||||||||||||
9/13/23 19:32 | 9/13/23 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Smith Brandon S. | CA | O | COO | S.d | -222 | 55.49 | 0 | -4 | -100 | 0 | D | ||||||||||||||
8/16/23 21:15 | 8/16/23 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Smith Brandon S. | CA | O | COO | S.d | -235 | 58.71 | 0 | -4 | -100 | 0 | D | ||||||||||||||
7/12/23 20:45 | 7/12/23 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Smith Brandon S. | CA | O | COO | S.d | -270 | 67.51 | 0 | -4 | -100 | 0 | D | ||||||||||||||
6/14/23 21:15 | 6/14/23 | PRTA | Prothena Corp Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Smith Brandon S. | CA | O | COO | S.d | -395 | 73.99 | 0 | -5 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |